Company profile: AgeX Therapeutics
1.1 - Company Overview
Company description
- Provider of novel therapeutics for age-related degenerative diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to AgeX Therapeutics
Zelluna
HQ: Norway
Website
- Description: Provider of TCR-based immunotherapies, developing off-the-shelf TCR-guided NK cell therapies for solid tumors. Pipeline includes a MAGE-A4 TCR-NK therapy for cancer advancing toward clinical trials, leveraging a wide range of TCRs.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Zelluna company profile →
Coya Therapeutics
HQ: United States
Website
- Description: Provider of Treg platform therapies for neurodegenerative, autoimmune, and metabolic diseases, including COYA 302, a biologic combination enhancing Treg function and reducing inflammation; COYA 301, a Treg-enhancing therapy; COYA 200 Series, Treg-derived exosomes to suppress inflammation; COYA 206, exosome polymer hybrids for targeted delivery; and COYA 101, autologous Treg cell therapy for ALS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Coya Therapeutics company profile →
Medistem
HQ: United States
Website
- Description: Provider of adult stem cell-based therapeutic products through development, acquisition, and commercialization. Founded in 2005, the company holds 16 families of patent applications, has numerous scientific publications, and generates revenue by out-licensing certain technologies. Main candidate: Endometrial Regenerative Cell (ERC).
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medistem company profile →
Outpace Bio
HQ: United States
Website
- Description: Provider of innovative cell therapies designed to enhance cancer treatment efficacy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Outpace Bio company profile →
Neurona Therapeutics
HQ: United States
Website
- Description: Provider of cell therapies for neurological disorders, including NRTX-1001, a one-time dose therapy for drug-resistant focal epilepsy using human MGE-type inhibitory GABAergic interneurons derived from pluripotent stem cells; myelinating glial cell therapy using human oligodendrocytes to restore myelin; and gene-edited neural cell therapies for targeted delivery to the CNS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neurona Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for AgeX Therapeutics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to AgeX Therapeutics
2.2 - Growth funds investing in similar companies to AgeX Therapeutics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for AgeX Therapeutics
4.2 - Public trading comparable groups for AgeX Therapeutics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →